Dr. Elion is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1701 14th St NW
Washington, DC 20009Phone+1 202-745-6142Fax+1 202-745-6152
Education & Training
Duke University HospitalResidency, Family Medicine, 1980 - 1983
Lewis Katz School of Medicine at Temple UniversityClass of 1980
Certifications & Licensure
DC State Medical License 1994 - 2024
NY State Medical License 1984 - 2007
PA State Medical License 2003 - 2004
NC State Medical License 1981 - 1988- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
- Super Doctor SuperDoctors.com
Clinical Trials
- SHARE: Simple HAART With Abacavir, Reyataz, and Epivir Start of enrollment: 2006 Aug 01
- Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) Start of enrollment: 2009 Jul 01
- Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) Start of enrollment: 2019 Jul 08
Publications & Presentations
PubMed
- 105 citationsIncreased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.Daniel R. Drozd, Mari M. Kitahata, Keri N. Althoff, Jinbing Zhang, Stephen J. Gange
Journal of Acquired Immune Deficiency Syndromes. 2017-08-15 - 103 citationsFinancial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065)Wafaa El-Sadr, Deborah Donnell, Geetha Beauchamp, H. Irene Hall, Lucia V. Torian
JAMA Internal Medicine. 2017-08-01 - 487 citationsPreexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesAlbert Y. Liu, Stephanie E. Cohen, Eric Vittinghoff, Peter L. Anderson, Susanne Doblecki-Lewis
JAMA Internal Medicine. 2016-01-01
Press Mentions
ViiV Healthcare Announces US FDA Approval of Apretude (Cabotegravir Extended-Release Injectable Suspension), the First and Only Long-Acting Injectable Option for HIV PreventionDecember 20th, 2021
Philly LGBTQ Conference Addresses Deadly Stigmatization of HIVJanuary 23rd, 2017
The 'Sexually Adventurous' Air Steward Who Was Widely Considered to Be HIV's Patient Zero in America DIDN'T Start the Epidemic, Study SaysMarch 13th, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
